- Home
- SNSE vs AMS Comparison
SNSE vs AMS Comparison
Compare SNSE & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNSE | AMS |
|---|---|---|
| Founded | 2005 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2M | 14.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SNSE | AMS |
|---|---|---|
| Price | $9.09 | $2.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $72.50 | N/A |
| AVG Volume (30 Days) | ★ 55.1K | 9.4K |
| Earning Date | 03-27-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $29,423,000.00 |
| Revenue This Year | N/A | $3.81 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 17.84 |
| 52 Week Low | $5.00 | $2.01 |
| 52 Week High | $18.35 | $3.11 |
Technical Indicators
Market Signals| Indicator | SNSE | AMS |
|---|---|---|
| Relative Strength Index (RSI) | 44.76 | 60.83 |
| Support Level | $8.72 | $2.09 |
| Resistance Level | $9.44 | $2.39 |
| Average True Range (ATR) | 0.69 | 0.07 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 34.62 | 54.82 |
Price Performance
Historical ComparisonAbout SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.